Loading clinical trials...
Loading clinical trials...
A comparative study on the efficacy of Tamsulosin, Solifenacin and Mirabegron in alleviating ureteral stent-related symptoms: a randomized controlled trial.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bir Hospital
Collaborators
NCT06979583 · Ureteral Stent-Related Symptom, Retrograde Intra-renal Surgery
NCT06930690 · Ureteral Stent-Related Symptom
NCT07018934 · Ureteral Stent-Related Symptoms
NCT06251336 · Ureteral Stent-Related Symptom, Urinary Tract Infections
NCT05598710 · Ureteral Stent-Related Symptom
NAMS, Bir Hospital
Kathmandu, Bagmati
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions